Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Bellerophon Therapeutics
(OTCPK:BLPH)
Intraday
$0.0551
0.0001
[0.18%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$0.0551
0.0001
[0.18%]
Last update: 10:24AM
Get Real Time Here
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Bellerophon Therapeutics Stock (OTC:BLPH)
Bellerophon Therapeutics Stock (OTC: BLPH)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, October 13, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Oct 13, 2023, 5:31PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Oct 13, 2023, 1:31PM
Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Oct 13, 2023, 1:14PM
Dow Jumps Over 200 Points; JPMorgan Earnings Top Estimates
Lisa Levin
-
Oct 13, 2023, 9:48AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Oct 13, 2023, 9:06AM
Thursday, October 12, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Oct 12, 2023, 5:31PM
Tuesday, October 10, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Oct 10, 2023, 1:09PM
Friday, July 28, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Jul 28, 2023, 12:36PM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Jul 28, 2023, 9:05AM
Why Coursera Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Jul 28, 2023, 7:57AM
Wednesday, July 26, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Jul 26, 2023, 5:32PM
Why PacWest Bancorp Shares Are Trading Higher By Over 35%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Jul 26, 2023, 8:09AM
Tuesday, July 25, 2023
Crude Oil Up 1%; Verizon Earnings Beat Views
Lisa Levin
-
Jul 25, 2023, 2:31PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Jul 25, 2023, 1:31PM
Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Jul 25, 2023, 1:11PM
What's Happening With Bellerophon Therapeutics Stock Today?
Vandana Singh
-
Jul 25, 2023, 12:53PM
Dow Surges 50 Points; General Electric Profit Tops Expectations
Lisa Levin
-
Jul 25, 2023, 12:32PM
Nasdaq Rises 70 Points; General Motors Posts Upbeat Earnings
Lisa Levin
-
Jul 25, 2023, 9:59AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Jul 25, 2023, 9:05AM
Bellerophon Therapeutics shares are trading lower after the company received a delisting notice.
Benzinga Newsdesk
-
Jul 25, 2023, 9:00AM
Why Expion360 Holdings Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Jul 25, 2023, 8:26AM
Bellerophon Therapeutics Would Be Delisted From NASDAQ At The Opening Of Business On July 28, 2023, Unless The Company Timely Requests A Hearing Before NASDAQ Hearings Panel To Address The Deficiencies And Present A Plan To Regain Compliance - 8K
Benzinga Newsdesk
-
Jul 25, 2023, 5:28AM
Wednesday, July 05, 2023
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In July
Lisa Levin
-
Jul 5, 2023, 8:51AM
Thursday, June 29, 2023
On June 24, 2023, Bellerophon Therapeutics Approved Reduction-In-Force Of Substantially All Of Its Employees, Including Its Executive Officers - Filing
Benzinga Newsdesk
-
Jun 29, 2023, 4:13PM
Tuesday, June 06, 2023
The Latest Analyst Ratings for Bellerophon Therapeutics
Benzinga Insights
-
Jun 6, 2023, 5:01PM
Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2023
Benzinga Insights
-
Jun 6, 2023, 11:00AM
HC Wainwright & Co. Maintains Buy on Bellerophon Therapeutics, Lowers Price Target to $2
Benzinga Newsdesk
-
Jun 6, 2023, 6:35AM
Laidlaw & Co. Downgrades Bellerophon Therapeutics to Hold
Benzinga Newsdesk
-
Jun 6, 2023, 4:47AM
Monday, June 05, 2023
Dow Drops Over 100 Points; Crude Oil Rises
Lisa Levin
-
Jun 5, 2023, 2:58PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Jun 5, 2023, 1:31PM
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Jun 5, 2023, 1:09PM
Nasdaq Rises 70 Points; ISM Services PMI Drops In May
Lisa Levin
-
Jun 5, 2023, 12:22PM
Bellerophon Therapeutics Stock Nosedive: Here's Why
Vandana Singh
-
Jun 5, 2023, 10:57AM
US Stocks Mixed; SAIC Posts Upbeat Results
Lisa Levin
-
Jun 5, 2023, 9:47AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Jun 5, 2023, 9:06AM
Bellerophon shares are trading lower after the company's Phase 3 REBUILD trial did not meet its primary endpoint.
Benzinga Newsdesk
-
Jun 5, 2023, 7:48AM
Bellerophon Therapeutics Shares Resume Trade
Benzinga Newsdesk
-
Jun 5, 2023, 7:32AM
Bellerophon Shares To Resume Trade At 7:30 AM ET
Charles Gross
-
Jun 5, 2023, 7:13AM
Bellerophon Says Phase 3 REBUILD Clinical Trial Did Not Meet Its Primary Endpoint
Benzinga Newsdesk
-
Jun 5, 2023, 7:01AM
Bellerophon Therapeutics Shares Halted; Pending News
Charles Gross
-
Jun 5, 2023, 6:57AM
Friday, May 19, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
May 19, 2023, 1:31PM
Wednesday, May 17, 2023
HC Wainwright & Co. Reinstates Buy on Bellerophon Therapeutics, Maintains $30 Price Target
Benzinga Newsdesk
-
May 17, 2023, 6:16AM
Tuesday, May 16, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
May 16, 2023, 1:31PM
Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
May 16, 2023, 1:13PM
Thursday, May 11, 2023
Bellerophon Therapeutics Announces Last Patient Has Completed Blinded Treatment In Phase 3 REBUILD Study For INOpulse In Fibrotic Interstitial Lung Disease; Company Expects To Report Top-Line Results From This Study In Mid-2023
Happy Mohamed
-
May 11, 2023, 8:32AM
Wednesday, May 10, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
May 10, 2023, 5:39PM
Tuesday, May 09, 2023
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2023
Benzinga Insights
-
May 9, 2023, 11:00AM
Laidlaw & Co. Initiates Coverage On Bellerophon Therapeutics with Buy Rating, Announces Price Target of $35
Benzinga Newsdesk
-
May 9, 2023, 10:06AM
Monday, April 10, 2023
10 Short Squeeze Candidates: Getty Images Tops List, PaxMedica Rejoins Top Five, MicroStrategy Moves Up And More
Chris Katje
-
Apr 10, 2023, 10:36AM
Tuesday, April 04, 2023
HC Wainwright & Co. Reiterates Buy on Bellerophon Therapeutics, Maintains $30 Price Target
Benzinga Newsdesk
-
Apr 4, 2023, 6:25AM
Show more